Mov Disord
Published

Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.

Authors

Cristina Gonzalez-Robles, Michèle Bartlett, Matthew Burnell, Caroline S Clarke, Shlomi Haar, Michele T Hu, Brook Huxford, Ashwani Jha, Michael Lawton, Alastair Noyce, Paola Piccini, Kuhan Pushparatnam, Lynn Rochester, Carroll Siu, Daniel van Wamelen, Caroline H Williams-Gray, Marie-Louise Zeissler, Henrik Zetterberg, Camille B Carroll, Thomas Foltynie, Rimona S Weil, Anette Schrag,
Read More

Abstract

Clinical trials of disease-modifying therapies in PD require valid and responsive primary outcome measures that are relevant to patients.

PMID:38140767 | DOI:

UK DRI Authors

Shlomi Haar profile

Dr Shlomi Haar

Emerging Leader

Developing digital biomarkers to detect and monitor motor conditions

Dr Shlomi Haar
Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg
Paul Matthews

Prof Paul Matthews

Group Leader

Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression

Prof Paul Matthews